-
1
-
-
33746139659
-
History of cannabis as a medicine: A review
-
Zuardi AW. History of cannabis as a medicine: a review. Rev Bras Psiquiatr. 2006;28(2):153-7
-
(2006)
Rev Bras Psiquiatr
, vol.28
, Issue.2
, pp. 153-157
-
-
Zuardi, A.W.1
-
2
-
-
0002454039
-
Structure of cannabidiol, a product isolated from the marihuana extract of Minnesota wild hemp
-
Adams R, Hunt M, Clark JH. Structure of cannabidiol, a product isolated from the marihuana extract of Minnesota wild hemp. J Am Chem Soc. 1940;62:196-200
-
(1940)
J Am Chem Soc
, vol.62
, pp. 196-200
-
-
Adams, R.1
Hunt, M.2
Clark, J.H.3
-
3
-
-
0014936107
-
Chemical basis of hashish activity
-
Mechoulam R, Shani A, Edery H, Grunfeld Y. Chemical basis of hashish activity. Science. 1970;169(945):611-2
-
(1970)
Science
, vol.169
, Issue.945
, pp. 611-612
-
-
Mechoulam, R.1
Shani, A.2
Edery, H.3
Grunfeld, Y.4
-
4
-
-
28844489930
-
A tale of two cannabinoids: The therapeutic rationale forcombining tetrahydrocannabinol and cannabidiol
-
Russo E, Guy GW. A tale of two cannabinoids: the therapeutic rationale forcombining tetrahydrocannabinol and cannabidiol. Med Hypotheses. 2006;66(2):234-46
-
(2006)
Med Hypotheses
, vol.66
, Issue.2
, pp. 234-246
-
-
Russo, E.1
Guy, G.W.2
-
5
-
-
0033538561
-
Discovery and characterization of endogenous cannabinoids
-
Martin BR, Mechoulam R, Razdan RK. Discovery and characterization of endogenous cannabinoids. Life Sci. 1999; 65(6-7):573-95
-
(1999)
Life Sci
, vol.65
, Issue.6-7
, pp. 573-595
-
-
Martin, B.R.1
Mechoulam, R.2
Razdan, R.K.3
-
6
-
-
79952198851
-
Endocannabinoids and psychiatric disorders - the road ahead
-
Mechoulam R. Endocannabinoids and psychiatric disorders - the road ahead. Rev Bras Psiquiatr. 2010;32(Suppl I):S5-6
-
(2010)
Rev Bras Psiquiatr
, vol.32
, Issue.SUPPL. I
-
-
Mechoulam, R.1
-
7
-
-
43749091232
-
Cannabis and psychiatric disorders: It is not only addiction
-
Leweke FM, Koethe D. Cannabis and psychiatric disorders: it is not only addiction. Addict Biol. 2008;13(2):264-75
-
(2008)
Addict Biol
, vol.13
, Issue.2
, pp. 264-275
-
-
Leweke, F.M.1
Koethe, D.2
-
8
-
-
0016210392
-
Cannabidiol interferes with the effects of delta 9 - tetrahydrocannabinol in man
-
Karniol IG, Shirakawa I, Kasinski N, Pfeferman A, Carlini EA. Cannabidiol interferes with the effects of delta 9 - tetrahydrocannabinol in man. Eur J Pharmacol. 1974;28(1):172-7
-
(1974)
Eur J Pharmacol
, vol.28
, Issue.1
, pp. 172-177
-
-
Karniol, I.G.1
Shirakawa, I.2
Kasinski, N.3
Pfeferman, A.4
Carlini, E.A.5
-
9
-
-
0020079139
-
Action of cannabidiol on the anxiety and other effects produced by D9-THC in normal subjects
-
Zuardi AW, Shirakawa I, Finkelfarb E, Karniol IG. Action of cannabidiol on the anxiety and other effects produced by D9-THC in normal subjects. Psychopharmacology (Berl). 1982;76(3):245-50
-
(1982)
Psychopharmacology (Berl)
, vol.76
, Issue.3
, pp. 245-250
-
-
Zuardi, A.W.1
Shirakawa, I.2
Finkelfarb, E.3
Karniol, I.G.4
-
10
-
-
0019771429
-
Comparative effects between cannabidiol and diazepam on neophobia, food intake and conflict behavior
-
Silveira Filho NG, Tufik S. Comparative effects between cannabidiol and diazepam on neophobia, food intake and conflict behavior. Res Commun Psychol Psychiatry Behav. 1981;6:25-6
-
(1981)
Res Commun Psychol Psychiatry Behav
, vol.6
, pp. 25-26
-
-
Silveira, F.N.G.1
Tufik, S.2
-
11
-
-
0842282227
-
Changes in the conditioned emotional response of rats induced by D9-THC, CBD and mixture of the two cannabinoids
-
Zuardi AW, Karniol IG. Changes in the conditioned emotional response of rats induced by D9-THC, CBD and mixture of the two cannabinoids. Arq Biol Tecnol. 1983;26:391-7
-
(1983)
Arq Biol Tecnol
, vol.26
, pp. 391-397
-
-
Zuardi, A.W.1
Karniol, I.G.2
-
14
-
-
33746647403
-
Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats
-
Resstel LB, Joca SR, Moreira FA, Corrêa FM, Guimarães FS. Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats. Behav Brain Res. 2006;172(2):294-8
-
(2006)
Behav Brain Res
, vol.172
, Issue.2
, pp. 294-298
-
-
Resstel, L.B.1
Joca, S.R.2
Moreira, F.A.3
Corrêa, F.M.4
Guimarães, F.S.5
-
15
-
-
65549106424
-
5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats
-
Resstel LB, Tavares RF, Lisboa SF, Joca SR, Corrêa FM, Guimarães FS. 5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats. Br J Pharmacol. 2009;156(1):181-8
-
(2009)
Br J Pharmacol
, vol.156
, Issue.1
, pp. 181-188
-
-
Resstel, L.B.1
Tavares, R.F.2
Lisboa, S.F.3
Joca, S.R.4
Corrêa, F.M.5
Guimarães, F.S.6
-
16
-
-
53649087673
-
Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats
-
Bitencourt RM, Pamplona FA, Takahashi RN. Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats. Eur Neuropsychopharmacol. 2008;18(12):849-59
-
(2008)
Eur Neuropsychopharmacol
, vol.18
, Issue.12
, pp. 849-859
-
-
Bitencourt, R.M.1
Pamplona, F.A.2
Takahashi, R.N.3
-
17
-
-
0025331052
-
Pharmacological characterization of cannabinoids in the elevated plus maze
-
Onaivi ES, Green MR, Martin BR. Pharmacological characterization of cannabinoids in the elevated plus maze. J Pharmacol Exp Ther. 1990;253(3):1002-9
-
(1990)
J Pharmacol Exp Ther
, vol.253
, Issue.3
, pp. 1002-1009
-
-
Onaivi, E.S.1
Green, M.R.2
Martin, B.R.3
-
18
-
-
71549171421
-
Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids
-
Campos AC, Guimarães FS. Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(8):1517-21
-
(2009)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.33
, Issue.8
, pp. 1517-1521
-
-
Campos, A.C.1
Guimarães, F.S.2
-
19
-
-
46649094780
-
Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats
-
Moreira FA, Campos AC, Guimarães FS. Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats. Psychopharmacology (Berl). 2008;199(2):223-30
-
(2008)
Psychopharmacology (Berl)
, vol.199
, Issue.2
, pp. 223-230
-
-
Moreira, F.A.1
Campos, A.C.2
Guimarães, F.S.3
-
20
-
-
0025266290
-
Antianxiety effect of cannabidiol in the elevated plus-maze
-
Guimarães FS, Chiaretti TM, Graeff FG, Zuardi AW. Antianxiety effect of cannabidiol in the elevated plus-maze. Psychopharmacology (Berl). 1990;100(4):558-9
-
(1990)
Psychopharmacology (Berl)
, vol.100
, Issue.4
, pp. 558-559
-
-
Guimarães, F.S.1
Chiaretti, T.M.2
Graeff, F.G.3
Zuardi, A.W.4
-
21
-
-
67649274432
-
Cannabidiol reverses the reduction in social interaction produced by low dose Delta(9)-tetrahydrocannabinol in rats
-
Malone DT, Jongejan D, Taylor DA. Cannabidiol reverses the reduction in social interaction produced by low dose Delta(9)-tetrahydrocannabinol in rats. Pharmacol Biochem Behav. 2009;93(2):91-6
-
(2009)
Pharmacol Biochem Behav
, vol.93
, Issue.2
, pp. 91-96
-
-
Malone, D.T.1
Jongejan, D.2
Taylor, D.A.3
-
22
-
-
77957239037
-
A behavioural comparison of acute and chronic Delta9tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice
-
Long LE, Chesworth R, Huang XF, McGregor IS, Arnold JC, Karl T. A behavioural comparison of acute and chronic Delta9tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice. Int J Neuropsychopharmacol. 2009;29:1-16
-
(2009)
Int J Neuropsychopharmacol
, vol.29
, pp. 1-16
-
-
Long, L.E.1
Chesworth, R.2
Huang, X.F.3
McGregor, I.S.4
Arnold, J.C.5
Karl, T.6
-
23
-
-
46649094780
-
Involvement of 5HT1A receptors in the anxiolyticlike effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats
-
Campos AC, Guimarães FS. Involvement of 5HT1A receptors in the anxiolyticlike effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats. Psychopharmacology (Berl). 2008;199(2):223-30
-
(2008)
Psychopharmacology (Berl)
, vol.199
, Issue.2
, pp. 223-230
-
-
Campos, A.C.1
Guimarães, F.S.2
-
24
-
-
0018947105
-
Chronic administration of cannabidiol to healthy volunteers and epileptic patients
-
Cunha JM, Carlini EA, Pereira AE, Ramos OL, Pimentel C, Gagliardi R, Sanvito WL, Lander N, Mechoulam R. Chronic administration of cannabidiol to healthy volunteers and epileptic patients. Pharmacology. 1980;21(3):175-85
-
(1980)
Pharmacology
, vol.21
, Issue.3
, pp. 175-185
-
-
Cunha, J.M.1
Carlini, E.A.2
Pereira, A.E.3
Ramos, O.L.4
Pimentel, C.5
Gagliardi, R.6
Sanvito, W.L.7
Lander, N.8
Mechoulam, R.9
-
25
-
-
0025837207
-
Controlled clinical trial of cannabidiol in Huntington's disease
-
Consroe P, Laguna J, Allender J, Snider S Ster L, Sandyr R, Kennedy K, Schram K. Controlled clinical trial of cannabidiol in Huntington's disease. Pharmacol Biochem Behav. 1991;40(3):701-8
-
(1991)
Pharmacol Biochem Behav
, vol.40
, Issue.3
, pp. 701-708
-
-
Consroe, P.1
Laguna, J.2
Allender, J.3
Snider, S.4
Ster, L.5
Sandyr, R.6
Kennedy, K.7
Schram, K.8
-
26
-
-
77950537848
-
National Science and Technology Institute for Translational Medicine (INCT-TM): Advancing the field of translational medicine and mental health
-
Hallak JE, Crippa JA, Quevedo J, Roesler R, Schröder N, Nardi AE, Kapczinski F. National Science and Technology Institute for Translational Medicine (INCT-TM): advancing the field of translational medicine and mental health. Rev Bras Psiquiatr. 2010;32(1):85-90
-
(2010)
Rev Bras Psiquiatr
, vol.32
, Issue.1
, pp. 85-90
-
-
Hallak, J.E.1
Crippa, J.A.2
Quevedo, J.3
Roesler, R.4
Schröder, N.5
Nardi, A.E.6
Kapczinski, F.7
-
28
-
-
10744224906
-
Effects of cannabidiol (CBD) on regional cerebral blood flow
-
Crippa JA, Zuardi AW, Garrido GE, Wichert-Ana L, Guarnieri R, Ferrari L, Azevedo-Marques PM, Hallak JE, McGuire PK, Filho Busatto G. Effects of cannabidiol (CBD) on regional cerebral blood flow. Neuropsychopharmacology. 2004;29(2):417-26
-
(2004)
Neuropsychopharmacology
, vol.29
, Issue.2
, pp. 417-426
-
-
Crippa, J.A.1
Zuardi, A.W.2
Garrido, G.E.3
Wichert-Ana, L.4
Guarnieri, R.5
Ferrari, L.6
Azevedo-Marques, P.M.7
Hallak, J.E.8
McGuire, P.K.9
Filho, B.G.10
-
29
-
-
58149520644
-
Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing
-
Fusar-Poli P, Crippa JA, Bhattacharyya S, Borgwardt SJ, Allen P, Martin-Santos R, Seal M, Surguladze SA, O'Carrol C, Atakan Z, Zuardi AW, McGuire PK. Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Arch Gen Psychiatry. 2009;66(1):95-105
-
(2009)
Arch Gen Psychiatry
, vol.66
, Issue.1
, pp. 95-105
-
-
Fusar-Poli, P.1
Crippa, J.A.2
Bhattacharyya, S.3
Borgwardt, S.J.4
Allen, P.5
Martin-Santos, R.6
Seal, M.7
Surguladze, S.A.8
O'Carrol, C.9
Atakan, Z.10
Zuardi, A.W.11
McGuire, P.K.12
-
30
-
-
78049317055
-
Modulation of effective connectivity during emotional processing by Delta9-tetrahydrocannabinol and cannabidiol
-
Fusar-Poli P, Allen P, Bhattacharyya S, Crippa JA, Mechelli A, Borgwardt S, Martin-Santos R, Seal ML, O'Carrol C, Atakan Z, Zuardi AW, McGuire P. Modulation of effective connectivity during emotional processing by Delta9-tetrahydrocannabinol and cannabidiol. Int J Neuropsychopharmacol. 2009;24:1-12
-
(2009)
Int J Neuropsychopharmacol
, vol.24
, pp. 1-12
-
-
Fusar-Poli, P.1
Allen, P.2
Bhattacharyya, S.3
Crippa, J.A.4
Mechelli, A.5
Borgwardt, S.6
Martin-Santos, R.7
Seal, M.L.8
O'Carrol, C.9
Atakan, Z.10
Zuardi, A.W.11
McGuire, P.12
-
31
-
-
77957236596
-
The effect of cannabidiol (CBD), a cannabis sativa constituent, on neural correlates of anxiety: A regional cerebral blood flow study
-
12th International Congress on Schizophrenia Research; San Diego, Mar 28-Apr 01
-
Crippa JA, Derenusson G, Zuardi AW, Wichert-Ana L, Duran F, Ferrari TB, Martin-Santos R, McGuire PK, Busatto GF, Hallak JE. The effect of cannabidiol (CBD), a cannabis sativa constituent, on neural correlates of anxiety: a regional cerebral blood flow study. Schizophrenia Bulletin; 12th International Congress on Schizophrenia Research; San Diego, Mar 28-Apr 01, 2009;35(Suppl 1):197-198
-
(2009)
Schizophrenia Bulletin
, vol.35
, Issue.SUPPL. 1
, pp. 197-198
-
-
Crippa, J.A.1
Derenusson, G.2
Zuardi, A.W.3
Wichert-Ana, L.4
Duran, F.5
Ferrari, T.B.6
Martin-Santos, R.7
McGuire, P.K.8
Busatto, G.F.9
Hallak, J.E.10
-
33
-
-
54249123588
-
Structural magnetic resonance imaging in anxiety disorders: An update of research findings
-
Ferrari MC, Busatto GF, McGuire PK, Crippa JA. Structural magnetic resonance imaging in anxiety disorders: an update of research findings. Rev Bras Psiquiatr. 2008;30(3):251-64
-
(2008)
Rev Bras Psiquiatr
, vol.30
, Issue.3
, pp. 251-264
-
-
Ferrari, M.C.1
Busatto, G.F.2
McGuire, P.K.3
Crippa, J.A.4
-
34
-
-
0025876938
-
Effects of cannabidiol in animal models predictive of antipsychotic activity
-
Zuardi AW, Rodrigues JA, Cunha JM. Effects of cannabidiol in animal models predictive of antipsychotic activity. Psychopharmacology (Berl). 1991;104(2):260-4
-
(1991)
Psychopharmacology (Berl)
, vol.104
, Issue.2
, pp. 260-264
-
-
Zuardi, A.W.1
Rodrigues, J.A.2
Cunha, J.M.3
-
35
-
-
17444393586
-
Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice
-
Moreira FA, Guimarães FS. Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice. Eur J Pharmacol. 2005;512(2- 3):199-205
-
(2005)
Eur J Pharmacol
, vol.512
, Issue.2-3
, pp. 199-205
-
-
Moreira, F.A.1
Guimarães, F.S.2
-
36
-
-
2442641276
-
Cannabidiol increases Fos expression in the nucleus accumbens but not in the dorsal striatum
-
Guimarães VM, Zuardi AW, Del Bel EA, Guimarães FS. Cannabidiol increases Fos expression in the nucleus accumbens but not in the dorsal striatum. Life Sci. 2004;75(5):633-8
-
(2004)
Life Sci
, vol.75
, Issue.5
, pp. 633-638
-
-
Guimarães, V.M.1
Zuardi, A.W.2
Del Bel, E.A.3
Guimarães, F.S.4
-
37
-
-
84876182471
-
Different effec os cannabinoids: Relevance to psychosis and schizophrenia
-
Leweke FM, Schneider U, Radwan M, Schmidt E, Emrich M. Different effec os cannabinoids: relevance to psychosis and schizophrenia. Rev Bras Psiquiatr. 2010;32(Suppl I):S15-30
-
(2010)
Rev Bras Psiquiatr
, vol.32
, Issue.SUPPL. I
-
-
Leweke, F.M.1
Schneider, U.2
Radwan, M.3
Schmidt, E.4
Emrich, M.5
-
38
-
-
0028323167
-
Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses
-
Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB Jr, Charney DS. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry. 1994;51(3):199-214
-
(1994)
Arch Gen Psychiatry
, vol.51
, Issue.3
, pp. 199-214
-
-
Krystal, J.H.1
Karper, L.P.2
Seibyl, J.P.3
Freeman, G.K.4
Delaney, R.5
Bremner, J.D.6
Heninger, G.R.7
Bowers Jr., M.B.8
Charney, D.S.9
-
39
-
-
33645832925
-
Effects of cannabidiol on (s)-ketamine-induced psychopathology in healthy volunteers
-
Bosi DC, Hallak JE, Dursun SM, Deakin JF, Zuardi AW. Effects of cannabidiol on (s)-ketamine-induced psychopathology in healthy volunteers. J Psychopharmacology. 2003;17:A55
-
(2003)
J Psychopharmacology
, vol.17
-
-
Bosi, D.C.1
Hallak, J.E.2
Dursun, S.M.3
Deakin, J.F.4
Zuardi, A.W.5
-
40
-
-
75749126485
-
Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology
-
Bhattacharyya S, Morrison PD, Fusar-Poli P, Martin-Santos R, Borgwardt S, Winton-Brown T, Nosarti C, O' Carroll CM, Seal M, Allen P, Mehta MA, Stone JM, Tunstall N, Giampietro V, Kapur S, Murray RM, Zuardi AW, Crippa JA, Atakan Z, McGuire PK. Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology. 2010;35(3):764-74
-
(2010)
Neuropsychopharmacology
, vol.35
, Issue.3
, pp. 764-774
-
-
Bhattacharyya, S.1
Morrison, P.D.2
Fusar-Poli, P.3
Martin-Santos, R.4
Borgwardt, S.5
Winton-Brown, T.6
Nosarti, C.7
O'carroll, C.M.8
Seal, M.9
Allen, P.10
Mehta, M.A.11
Stone, J.M.12
Tunstall, N.13
Giampietro, V.14
Kapur, S.15
Murray, R.M.16
Zuardi, A.W.17
Crippa, J.A.18
Atakan, Z.19
McGuire, P.K.20
more..
-
41
-
-
43749124214
-
Effects of cannabidiol on schizophrenialike symptoms in people who use cannabis
-
Morgan CJ, Curran HV. Effects of cannabidiol on schizophrenialike symptoms in people who use cannabis. Br J Psychiatry. 2008;192(4):306-7
-
(2008)
Br J Psychiatry
, vol.192
, Issue.4
, pp. 306-307
-
-
Morgan, C.J.1
Curran, H.V.2
-
42
-
-
46949099370
-
Cannabis and schizophrenia: Towards a cannabinoid hypothesis of schizophrenia
-
Müller-Vahl KR, Emrich HM. Cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia. Expert Rev Neurother. 2008;8(7):1037-48
-
(2008)
Expert Rev Neurother
, vol.8
, Issue.7
, pp. 1037-1048
-
-
Müller-Vahl, K.R.1
Emrich, H.M.2
-
43
-
-
77950542042
-
Performance of schizophrenic patients in the Stroop Color Word Test and electrodermal responsiveness after acute administration of cannabidiol (CBD)
-
Hallak JE, Machado-de-Sousa JP, Crippa JA, Sanches RF, Trzesniak C, Chaves C, Bernardo SA, Regalo SC, Zuardi AW. Performance of schizophrenic patients in the Stroop Color Word Test and electrodermal responsiveness after acute administration of cannabidiol (CBD). Rev Bras Psiquiatr. 2010;32(1):56-61
-
(2010)
Rev Bras Psiquiatr
, vol.32
, Issue.1
, pp. 56-61
-
-
Hallak, J.E.1
Machado-de-Sousa, J.P.2
Crippa, J.A.3
Sanches, R.F.4
Trzesniak, C.5
Chaves, C.6
Bernardo, S.A.7
Regalo, S.C.8
Zuardi, A.W.9
-
44
-
-
0028881791
-
Anti-psychotic effect of cannabidiol
-
Zuardi AW, Morais SL, Guimarães FS, Mechoulam R. Anti-psychotic effect of cannabidiol. J Clin Psychiatry.1995;56(10):485-6
-
(1995)
J Clin Psychiatry
, vol.56
, Issue.10
, pp. 485-486
-
-
Zuardi, A.W.1
Morais, S.L.2
Guimarães, F.S.3
Mechoulam, R.4
-
45
-
-
33748320954
-
Cannabidiol monotherapy for treatment-resistant schizophrenia
-
Zuardi AW, Hallak JE, Dursun SM, Morais SL, Sanches RF, Musty RE, Crippa JA. Cannabidiol monotherapy for treatment-resistant schizophrenia. J Psychopharmacol. 2006;20(5):683-6
-
(2006)
J Psychopharmacol
, vol.20
, Issue.5
, pp. 683-686
-
-
Zuardi, A.W.1
Hallak, J.E.2
Dursun, S.M.3
Morais, S.L.4
Sanches, R.F.5
Musty, R.E.6
Crippa, J.A.7
-
46
-
-
33645821022
-
Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug
-
Zuardi AW, Crippa JA, Hallak JE, Moreira FA, Guimarães FS. Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug. Braz J Med Biol Res. 2006;39(4):421-9
-
(2006)
Braz J Med Biol Res
, vol.39
, Issue.4
, pp. 421-429
-
-
Zuardi, A.W.1
Crippa, J.A.2
Hallak, J.E.3
Moreira, F.A.4
Guimarães, F.S.5
-
47
-
-
84876175227
-
Cannabidiol as an antipsychotic. A double-blind, controlled clinical trial on cannabidiol vs. amisulpride in acute schizophrenia
-
Leweke FM, Koethe D, Gerth CW, Nolden BM, Schreiber D, Hänsel A, Neatby MA, Juelicher A, Hellmich M, Klosterkötter J. Cannabidiol as an antipsychotic. A double-blind, controlled clinical trial on cannabidiol vs. amisulpride in acute schizophrenia. Eur Psychiatry. 2007;22:S14.02
-
(2007)
Eur Psychiatry
, vol.22
-
-
Leweke, F.M.1
Koethe, D.2
Gerth, C.W.3
Nolden, B.M.4
Schreiber, D.5
Hänsel, A.6
Neatby, M.A.7
Juelicher, A.8
Hellmich, M.9
Klosterkötter, J.10
-
48
-
-
0029927520
-
Psychotic symptoms in Parkinson's disease patients with dementia
-
Naimark D, Jackson E, Rockwell E, Jeste DV. Psychotic symptoms in Parkinson's disease patients with dementia. J Am Geriatr Soc. 1996;44(3):296-9
-
(1996)
J Am Geriatr Soc
, vol.44
, Issue.3
, pp. 296-299
-
-
Naimark, D.1
Jackson, E.2
Rockwell, E.3
Jeste, D.V.4
-
50
-
-
70449375201
-
Cannabidiol for the treatment of psychosis in Parkinson's disease
-
Zuardi AW, Crippa JA, Hallak JE, Pinto JP, Chagas MH, Rodrigues GG, Dursun SM, Tumas V. Cannabidiol for the treatment of psychosis in Parkinson's disease. J Psychopharmacol. 2009;23(8):979-83
-
(2009)
J Psychopharmacol
, vol.23
, Issue.8
, pp. 979-983
-
-
Zuardi, A.W.1
Crippa, J.A.2
Hallak, J.E.3
Pinto, J.P.4
Chagas, M.H.5
Rodrigues, G.G.6
Dursun, S.M.7
Tumas, V.8
-
51
-
-
0015817954
-
Pharmacological interaction between cannabidiol and delta 9-tetrahydrocannabinol
-
Karniol IG, Carlini EA. Pharmacological interaction between cannabidiol and delta 9-tetrahydrocannabinol. Psychopharmacologia. 1973;33(1):53-70
-
(1973)
Psychopharmacologia
, vol.33
, Issue.1
, pp. 53-70
-
-
Karniol, I.G.1
Carlini, E.A.2
-
52
-
-
0016198967
-
Effects of cannabidiol and delta-9-tetrahydrocannabinol on operant behavior
-
Davis WM, Borgen LA. Effects of cannabidiol and delta-9-tetrahydrocannabinol on operant behavior. Res Commun Chem Pathol Pharmacol. 1974;9(3): 453-62
-
(1974)
Res Commun Chem Pathol Pharmacol
, vol.9
, Issue.3
, pp. 453-462
-
-
Davis, W.M.1
Borgen, L.A.2
-
53
-
-
0017652749
-
Hypnoticlike effects of cannabidiol in the rat
-
Monti JM. Hypnoticlike effects of cannabidiol in the rat. Psychopharmacology (Berl). 1977;55(3):263-5
-
(1977)
Psychopharmacology (Berl)
, vol.55
, Issue.3
, pp. 263-265
-
-
Monti, J.M.1
-
54
-
-
0019604414
-
Hypnotic and antiepileptic effects of cannabidiol
-
Carlini EA, Cunha JM. Hypnotic and antiepileptic effects of cannabidiol. J Clin Pharmacol. 1981;21(8-9 Suppl):417S-27S.
-
(1981)
J Clin Pharmacol
, vol.21
, Issue.8-9 SUPPL.
-
-
Carlini, E.A.1
Cunha, J.M.2
-
55
-
-
74349103148
-
Validity of a Brazilian version of the Zung self-rating depression scale for screening of depression in patients with Parkinson's disease
-
Chagas MH, Tumas V, Loureiro SR, Hallak JE, Trzesniak C, de Sousa JP, Rodrigues GG, Santos Filho A, Crippa JA. Validity of a Brazilian version of the Zung self-rating depression scale for screening of depression in patients with Parkinson's disease. Parkinsonism Relat Disord. 2010;16(1):42-5
-
(2010)
Parkinsonism Relat Disord
, vol.16
, Issue.1
, pp. 42-45
-
-
Chagas, M.H.1
Tumas, V.2
Loureiro, S.R.3
Hallak, J.E.4
Trzesniak, C.5
de Sousa, J.P.6
Rodrigues, G.G.7
Santos, F.A.8
Crippa, J.A.9
-
56
-
-
0027263719
-
Effect of cannabidiol on plasma prolactin, growth hormone and cortisol in human volunteers
-
Zuardi AW, Guimarães FS, Moreira AC. Effect of cannabidiol on plasma prolactin, growth hormone and cortisol in human volunteers. Braz J Med Biol Res. 1993;26(2):213-7
-
(1993)
Braz J Med Biol Res
, vol.26
, Issue.2
, pp. 213-217
-
-
Zuardi, A.W.1
Guimarães, F.S.2
Moreira, A.C.3
-
57
-
-
54249156391
-
Cannabidiol: From an inactive cannabinoid to a drug with wide spectrum of action
-
Zuardi AW. Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action. Rev Bras Psiquiatr. 2008;30(3):271-80
-
(2008)
Rev Bras Psiquiatr
, vol.30
, Issue.3
, pp. 271-280
-
-
Zuardi, A.W.1
-
58
-
-
33746518572
-
Cannabidiol, a constituent of Cannabis sativa, modulates sleep in rats
-
Murillo-Rodríguez E, Millán-Aldaco D, Palomero-Rivero M, Mechoulam R, Drucker-Colín R. Cannabidiol, a constituent of Cannabis sativa, modulates sleep in rats. FEBS Lett. 2006;580(18):4337-45
-
(2006)
FEBS Lett
, vol.580
, Issue.18
, pp. 4337-4345
-
-
Murillo-Rodríguez, E.1
Millán-Aldaco, D.2
Palomero-Rivero, M.3
Mechoulam, R.4
Drucker-Colín, R.5
-
59
-
-
70349189518
-
Non-psychotropic plant cannabinoids: New therapeutic opportunities from an ancient herb
-
Izzo AA, Borrelli F, Capasso R, Di Marzo V, Mechoulam R. Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol Sci. 2009;30(10):515-27
-
(2009)
Trends Pharmacol Sci
, vol.30
, Issue.10
, pp. 515-527
-
-
Izzo, A.A.1
Borrelli, F.2
Capasso, R.3
Di Marzo, V.4
Mechoulam, R.5
-
60
-
-
74549165354
-
Antidepressantlike effects of cannabidiol in mice: Possible involvement of 5-HT1A receptors
-
Zanelati TV, Biojone C, Moreira FA, Guimarães FS, Joca SR. Antidepressantlike effects of cannabidiol in mice: possible involvement of 5-HT1A receptors. Br J Pharmacol. 2010;159(1):122-8
-
(2010)
Br J Pharmacol
, vol.159
, Issue.1
, pp. 122-128
-
-
Zanelati, T.V.1
Biojone, C.2
Moreira, F.A.3
Guimarães, F.S.4
Joca, S.R.5
-
61
-
-
0015656165
-
Cannabidiol and cannabis sativa extract protect mice and rats against convulsive agents
-
Carlini EA, Leite JR, Tanhauser M, Berardi AC. Cannabidiol and cannabis sativa extract protect mice and rats against convulsive agents. J Pharm Pharmacol. 1973;25(8):664-5
-
(1973)
J Pharm Pharmacol
, vol.25
, Issue.8
, pp. 664-665
-
-
Carlini, E.A.1
Leite, J.R.2
Tanhauser, M.3
Berardi, A.C.4
-
62
-
-
0015543610
-
Effect of cannabidiol and other Cannabis sativa compounds on hippocampal seizures discharges
-
Izquierdo I, Orsingher OA, Berardi AC. Effect of cannabidiol and other Cannabis sativa compounds on hippocampal seizures discharges. Psychopharmacologia. 1973;28(1):95-102
-
(1973)
Psychopharmacologia
, vol.28
, Issue.1
, pp. 95-102
-
-
Izquierdo, I.1
Orsingher, O.A.2
Berardi, A.C.3
-
63
-
-
0016208043
-
Anticonvulsant properties of cannabidiol
-
Turkanis SA, Cely W, Olsen DM, Karler R. Anticonvulsant properties of cannabidiol. Res Communic Chem Pathol Pharmacol. 1974;8(2):231-46
-
(1974)
Res Communic Chem Pathol Pharmacol
, vol.8
, Issue.2
, pp. 231-246
-
-
Turkanis, S.A.1
Cely, W.2
Olsen, D.M.3
Karler, R.4
-
64
-
-
18844381146
-
Cannabinoids in bipolar affective disorder: A review and discussion of their therapeutic potential
-
Ashton CH, Moore PB, Gallagher P, Young AH. Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential. J Psychopharmacol. 2005;19(3):293-300
-
(2005)
J Psychopharmacol
, vol.19
, Issue.3
, pp. 293-300
-
-
Ashton, C.H.1
Moore, P.B.2
Gallagher, P.3
Young, A.H.4
-
65
-
-
77958509626
-
Effects of cannabidiol on amphetamineinduced oxidative stress generation in an animal model of mania
-
In press
-
Valvassori SS, Elias G, de Souza B, Petronilho F, Dal-Pizzol F, Kapczinski F, Trzesniak C, Tumas V, Dursun S, Chagas MH, Hallak JE, Zuardi AW, Quevedo J, Crippa JA. Effects of cannabidiol on amphetamineinduced oxidative stress generation in an animal model of mania. J Psychopharmacol. In press 2009
-
(2009)
J Psychopharmacol
-
-
Valvassori, S.S.1
Elias, G.2
de Souza, B.3
Petronilho, F.4
Dal-Pizzol, F.5
Kapczinski, F.6
Trzesniak, C.7
Tumas, V.8
Dursun, S.9
Chagas, M.H.10
Hallak, J.E.11
Zuardi, A.W.12
Quevedo, J.13
Crippa, J.A.14
-
66
-
-
76249132113
-
Cannabidiol was ineffective for manic episode of bipolar affective disorder
-
Zuardi A, Crippa J, Dursun S, Morais S, Vilela J, Sanches R, Hallak J. Cannabidiol was ineffective for manic episode of bipolar affective disorder. J Psychopharmacol. 2010;24(1):135-7
-
(2010)
J Psychopharmacol
, vol.24
, Issue.1
, pp. 135-137
-
-
Zuardi, A.1
Crippa, J.2
Dursun, S.3
Morais, S.4
Vilela, J.5
Sanches, R.6
Hallak, J.7
-
67
-
-
79952196961
-
Pharmacological and Psychosocial Interventions for Cannabis Use Disorders
-
In press
-
Budney AJ, Vandrey RG, Stanger C. Pharmacological and Psychosocial Interventions for Cannabis Use Disorders. Rev Bras Psiquiatr. In press 2010
-
(2010)
Rev Bras Psiquiatr
-
-
Budney, A.J.1
Vandrey, R.G.2
Stanger, C.3
-
68
-
-
67649400461
-
Pharmacotherapy for cannabis dependence: How close are we?
-
Vandrey R, Haney M. Pharmacotherapy for cannabis dependence: how close are we? CNS Drugs. 2009;23(7):543-53
-
(2009)
CNS Drugs
, vol.23
, Issue.7
, pp. 543-553
-
-
Vandrey, R.1
Haney, M.2
-
69
-
-
72449197981
-
Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances
-
Ren Y, Whittard J, Higuera-Matas A, Morris CV, Hurd YL. Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances. J Neurosci. 2009; 29(47):14764-9
-
(2009)
J Neurosci
, vol.29
, Issue.47
, pp. 14764-14769
-
-
Ren, Y.1
Whittard, J.2
Higuera-Matas, A.3
Morris, C.V.4
Hurd, Y.L.5
-
70
-
-
0034792214
-
Marijuana abstinence effects in marijuana smokers maintained in their home environment
-
Budney AJ, Hughes JR, Moore BA, Novy PL. Marijuana abstinence effects in marijuana smokers maintained in their home environment. Arch Gen Psychiatry. 2001;58(10):917-24
-
(2001)
Arch Gen Psychiatry
, vol.58
, Issue.10
, pp. 917-924
-
-
Budney, A.J.1
Hughes, J.R.2
Moore, B.A.3
Novy, P.L.4
-
71
-
-
0032776569
-
Substance use among young people: The relationship between perceived functions and intentions
-
Boys A, Marsden J, Griffiths P, Fountain J, Stillwell G, Strang J. Substance use among young people: the relationship between perceived functions and intentions. Addiction. 1999;94(7):1043-50
-
(1999)
Addiction
, vol.94
, Issue.7
, pp. 1043-1050
-
-
Boys, A.1
Marsden, J.2
Griffiths, P.3
Fountain, J.4
Stillwell, G.5
Strang, J.6
-
72
-
-
0019604393
-
The efficacy and safety of nabilone (a synthetic cannabinoid) in the treatment of anxiety
-
Fabre LF, McLendon D. The efficacy and safety of nabilone (a synthetic cannabinoid) in the treatment of anxiety. J Clin Pharmacol. 1981;21(8-9 Suppl):377S-382S.
-
(1981)
J Clin Pharmacol
, vol.21
, Issue.8-9 SUPPL
-
-
Fabre, L.F.1
McLendon, D.2
-
73
-
-
0019415351
-
Nabilone, a cannabinol derivative, in the treatment of anxiety neurosis
-
Ilaria RL, Thornby JI, Fann WE. Nabilone, a cannabinol derivative, in the treatment of anxiety neurosis. Curr Ther Res. 1981;29:943-9
-
(1981)
Curr Ther Res
, vol.29
, pp. 943-949
-
-
Ilaria, R.L.1
Thornby, J.I.2
Fann, W.E.3
-
74
-
-
26044436588
-
Neurophysiological and subjective profile of marihuana with varying concentrations of cannabinoids
-
Ilan AB, Gevins A, Coleman M, Elsohly MA, de Wit H. Neurophysiological and subjective profile of marihuana with varying concentrations of cannabinoids. Behav Pharmacol. 2005;16(5-6):487-96
-
(2005)
Behav Pharmacol
, vol.16
, Issue.5-6
, pp. 487-496
-
-
Ilan, A.B.1
Gevins, A.2
Coleman, M.3
Elsohly, M.A.4
de Wit, H.5
-
75
-
-
4043096916
-
Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomized double blind placebo controlled crossover trial
-
Svendson KB, Troels SJ, Fleming WB. Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomized double blind placebo controlled crossover trial. BMJ. 2004;329(7460): 253-7
-
(2004)
BMJ
, vol.329
, Issue.7460
, pp. 253-257
-
-
Svendson, K.B.1
Troels, S.J.2
Fleming, W.B.3
-
76
-
-
72849125686
-
Cannabis and anxiety: A critical review of the evidence
-
Crippa JA, Zuardi AW, Martín-Santos R, Bhattacharyya S, Atakan Z, McGuire P, Fusar-Poli P. Cannabis and anxiety: a critical review of the evidence. Hum Psychopharmacol. 2009;24(7):515-23
-
(2009)
Hum Psychopharmacol
, vol.24
, Issue.7
, pp. 515-523
-
-
Crippa, J.A.1
Zuardi, A.W.2
Martín-Santos, R.3
Bhattacharyya, S.4
Atakan, Z.5
McGuire, P.6
Fusar-Poli, P.7
-
77
-
-
79851503776
-
Behavioral cognitive and psychophysiological effects os cannabinoids: Relevance to psychosis and schizophrenia
-
Sewell RA, Skosnik PD, Garcia-Sosa I, Ranganathan M, D'Souza DC. Behavioral cognitive and psychophysiological effects os cannabinoids: relevance to psychosis and schizophrenia. Rev Bras Psiquiatr. 2010;32(Suppl I):S15-30
-
(2010)
Rev Bras Psiquiatr
, vol.32
, Issue.SUPPL. I
-
-
Sewell, R.A.1
Skosnik, P.D.2
Garcia-Sosa, I.3
Ranganathan, M.4
D'souza, D.C.5
-
78
-
-
67649265233
-
Synthetic delta-9-tetrahydrocannabinol (dronabinol) can improve the symptoms of schizophrenia
-
Schwarcz G, Karajgi B, McCarthy R. Synthetic delta-9-tetrahydrocannabinol (dronabinol) can improve the symptoms of schizophrenia. J Clin Psychopharmacol. 2009;29(3):255-8
-
(2009)
J Clin Psychopharmacol
, vol.29
, Issue.3
, pp. 255-258
-
-
Schwarcz, G.1
Karajgi, B.2
McCarthy, R.3
-
79
-
-
0036680031
-
Effects of oral THC maintenance on smoked marijuana self-administration
-
Hart CL, Haney M, Ward AS, Fischman MW, Foltin RW. Effects of oral THC maintenance on smoked marijuana self-administration. Drug Alcohol Depend. 2002;67(3):301-9
-
(2002)
Drug Alcohol Depend
, vol.67
, Issue.3
, pp. 301-309
-
-
Hart, C.L.1
Haney, M.2
Ward, A.S.3
Fischman, M.W.4
Foltin, R.W.5
-
80
-
-
41949083220
-
Use of dronabinol for cannabis dependence: Two case reports and review
-
Levin FR, Kleber HD. Use of dronabinol for cannabis dependence: two case reports and review. Am J Addict. 2008;17(2):161-4
-
(2008)
Am J Addict
, vol.17
, Issue.2
, pp. 161-164
-
-
Levin, F.R.1
Kleber, H.D.2
-
81
-
-
0346688560
-
Marijuana withdrawal in humans: Effects of oral THC or divalproex
-
Haney M, Hart CL, Vosburg SK, Nasser J, Bennett A, Zubaran C, Foltin RW. Marijuana withdrawal in humans: effects of oral THC or divalproex. Neuropsychopharmacology. 2004;29(1):158-70
-
(2004)
Neuropsychopharmacology
, vol.29
, Issue.1
, pp. 158-170
-
-
Haney, M.1
Hart, C.L.2
Vosburg, S.K.3
Nasser, J.4
Bennett, A.5
Zubaran, C.6
Foltin, R.W.7
-
82
-
-
0015757749
-
(-) Delta 9 THC as an hypnotic. An experimental study of three dose levels
-
Cousens K, DiMascio A. (-) Delta 9 THC as an hypnotic. An experimental study of three dose levels. Psychopharmacologia. 1973;33(4):355-64
-
(1973)
Psychopharmacologia
, vol.33
, Issue.4
, pp. 355-364
-
-
Cousens, K.1
Dimascio, A.2
-
83
-
-
76249123626
-
The effects of nabilone on sleep in fibromyalgia: Results of a randomized controlled trial
-
Ware MA, Fitzcharles MA, Joseph L, Shir Y. The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial. Anesth Analg. 2010;110(2):604-10
-
(2010)
Anesth Analg
, vol.110
, Issue.2
, pp. 604-610
-
-
Ware, M.A.1
Fitzcharles, M.A.2
Joseph, L.3
Shir, Y.4
-
84
-
-
0031855913
-
The use of cannabis as a mood stabilizer in bipolar disorder: Anecdotal evidence and the need for clinical research
-
Grinspoon L, Bakalar JB. The use of cannabis as a mood stabilizer in bipolar disorder: anecdotal evidence and the need for clinical research. J Psychoactive Drugs. 1998;30(2):171-7
-
(1998)
J Psychoactive Drugs
, vol.30
, Issue.2
, pp. 171-177
-
-
Grinspoon, L.1
Bakalar, J.B.2
-
85
-
-
67650504086
-
The psychiatric side-effects of rimonabant
-
Moreira FA, Crippa JA. The psychiatric side-effects of rimonabant. Rev Bras Psiquiatr. 2009;31(2):145-53
-
(2009)
Rev Bras Psiquiatr
, vol.31
, Issue.2
, pp. 145-153
-
-
Moreira, F.A.1
Crippa, J.A.2
-
86
-
-
0035048803
-
Blockade of effects of smoked marijuana by the CB1- selective cannabinoid receptor antagonist SR141716
-
Huestis MA, Gorelick DA, Heishman SJ, Preston KL, Nelson RA, Moolchan ET, Frank RA. Blockade of effects of smoked marijuana by the CB1- selective cannabinoid receptor antagonist SR141716. Arch Gen Psychiatry. 2001;58(4):322-8
-
(2001)
Arch Gen Psychiatry
, vol.58
, Issue.4
, pp. 322-328
-
-
Huestis, M.A.1
Gorelick, D.A.2
Heishman, S.J.3
Preston, K.L.4
Nelson, R.A.5
Moolchan, E.T.6
Frank, R.A.7
-
87
-
-
33344467124
-
The cannabinoid CB1 receptor antagonist rimonabant attenuates the hypotensive effect of smoked marijuana in male smokers
-
Gorelick DA, Heishman SJ, Preston KL, Nelson RA, Moolchan ET, Huestis MA. The cannabinoid CB1 receptor antagonist rimonabant attenuates the hypotensive effect of smoked marijuana in male smokers. Am Heart J. 2006;151(3):754.e1-754.e5
-
(2006)
Am Heart J
, vol.151
, Issue.3
-
-
Gorelick, D.A.1
Heishman, S.J.2
Preston, K.L.3
Nelson, R.A.4
Moolchan, E.T.5
Huestis, M.A.6
-
88
-
-
34848831162
-
Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users
-
Huestis MA, Boyd SJ, Heishman SJ, Preston KL, Bonnet D, Le Fur G, Gorelick DA. Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users. Psychopharmacology (Berl). 2007;194(4):505-15
-
(2007)
Psychopharmacology (Berl)
, vol.194
, Issue.4
, pp. 505-515
-
-
Huestis, M.A.1
Boyd, S.J.2
Heishman, S.J.3
Preston, K.L.4
Bonnet, D.5
Le Fur, G.6
Gorelick, D.A.7
-
89
-
-
0035879079
-
Functional interaction between opioid and cannabinoid receptors in drug self-administration
-
Navarro M, Carrera MR, Fratta W, Valverde O, Cossu G, Fattore L, Chowen JA, Gomez R, del Arco I, Villanua MA, Maldonado R, Koob GF, Rodriguez de Fonseca F. Functional interaction between opioid and cannabinoid receptors in drug self-administration. J Neurosci. 2001;21(14):5344-50
-
(2001)
J Neurosci
, vol.21
, Issue.14
, pp. 5344-5350
-
-
Navarro, M.1
Carrera, M.R.2
Fratta, W.3
Valverde, O.4
Cossu, G.5
Fattore, L.6
Chowen, J.A.7
Gomez, R.8
del Arco, I.9
Villanua, M.A.10
Maldonado, R.11
Koob, G.F.12
de Fonseca, F.R.13
-
90
-
-
0034770150
-
A cannabinoid mechanism in relapse to cocaine seeking
-
De Vries TJ, Shaham Y, Homberg JR, Crombag H, Schuurman K, Dieben J, Vanderschuren LJ, Schoffelmeer AN. A cannabinoid mechanism in relapse to cocaine seeking. Nat Med. 2001;7(10):1151-4
-
(2001)
Nat Med
, vol.7
, Issue.10
, pp. 1151-1154
-
-
de Vries, T.J.1
Shaham, Y.2
Homberg, J.R.3
Crombag, H.4
Schuurman, K.5
Dieben, J.6
Vanderschuren, L.J.7
Schoffelmeer, A.N.8
-
91
-
-
4444376204
-
Suppressing effect of the cannabinoid CB1 receptor antagonist, SR 141716, on alcohol's motivational properties in alcohol-preferring rats
-
Colombo G, Vacca G, Serra S, Carai MA, Gessa GL. Suppressing effect of the cannabinoid CB1 receptor antagonist, SR 141716, on alcohol's motivational properties in alcohol-preferring rats. Eur J Pharmacol. 2004;498(1-3):119-23
-
(2004)
Eur J Pharmacol
, vol.498
, Issue.1-3
, pp. 119-123
-
-
Colombo, G.1
Vacca, G.2
Serra, S.3
Carai, M.A.4
Gessa, G.L.5
-
92
-
-
0036748948
-
SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats
-
Cohen C, Perrault G, Voltz C, Steinberg R, Soubrié P. SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats. Behav Pharmacol. 2002;13(5-6):451-63
-
(2002)
Behav Pharmacol
, vol.13
, Issue.5-6
, pp. 451-463
-
-
Cohen, C.1
Perrault, G.2
Voltz, C.3
Steinberg, R.4
Soubrié, P.5
-
93
-
-
58349105218
-
A randomized controlled trial of adding the nicotine patch to rimonabant for smoking cessation: Efficacy, safety and weight gain
-
CIRRUS Study Group
-
Rigotti NA, Gonzales D, Dale LC, Lawrence D, Chang Y; CIRRUS Study Group. A randomized controlled trial of adding the nicotine patch to rimonabant for smoking cessation: efficacy, safety and weight gain. Addiction. 2009;104(2):266-76
-
(2009)
Addiction
, vol.104
, Issue.2
, pp. 266-276
-
-
Rigotti, N.A.1
Gonzales, D.2
Dale, L.C.3
Lawrence, D.4
Chang, Y.5
-
94
-
-
58349117493
-
Trial comes too late as psychiatric side effects end hope for rimonabant
-
Stapleton JA. Trial comes too late as psychiatric side effects end hope for rimonabant. Addiction. 2009;104(2):277-8
-
(2009)
Addiction
, vol.104
, Issue.2
, pp. 277-278
-
-
Stapleton, J.A.1
-
95
-
-
0033059089
-
Blockade of cannabinoid (CB1) receptors by 141716 selectively antagonizes drug-induced reinstatement of exploratory behaviour in gerbils
-
Poncelet M, Barnouin MC, Brelière JC, Le Fur G, Soubrié P. Blockade of cannabinoid (CB1) receptors by 141716 selectively antagonizes drug-induced reinstatement of exploratory behaviour in gerbils. Psychopharmacology (Berl). 1999;144(2):144-50
-
(1999)
Psychopharmacology (Berl)
, vol.144
, Issue.2
, pp. 144-150
-
-
Poncelet, M.1
Barnouin, M.C.2
Brelière, J.C.3
Le Fur, G.4
Soubrié, P.5
-
96
-
-
2942538034
-
Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder
-
Meta-Trial Study Group
-
Meltzer HY, Arvanitis L, Bauer D, Rein W; Meta-Trial Study Group. Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder. Am J Psychiatry. 2004;161(6):975-84
-
(2004)
Am J Psychiatry
, vol.161
, Issue.6
, pp. 975-984
-
-
Meltzer, H.Y.1
Arvanitis, L.2
Bauer, D.3
Rein, W.4
-
97
-
-
33750730662
-
Oral delta-9- tetrahydrocannabinol suppresses cannabis withdrawal symptoms
-
Budney AJ, Vandrey RG, Hughes JR, Moore BA, Bahrenburg B. Oral delta-9- tetrahydrocannabinol suppresses cannabis withdrawal symptoms. Drug Alcohol Depend. 2007;86(1):22-9
-
(2007)
Drug Alcohol Depend
, vol.86
, Issue.1
, pp. 22-29
-
-
Budney, A.J.1
Vandrey, R.G.2
Hughes, J.R.3
Moore, B.A.4
Bahrenburg, B.5
-
98
-
-
0030456030
-
Do patients use marijuana as an antidepressant?
-
Gruber AJ, Pope HG, Brown ME. Do patients use marijuana as an antidepressant? Depression. 1996;4:77-80
-
(1996)
Depression
, vol.4
, pp. 77-80
-
-
Gruber, A.J.1
Pope, H.G.2
Brown, M.E.3
-
99
-
-
69249116618
-
Imaging the neural effects of cannabinoids: Current status and future opportunities for psychopharmacology
-
Bhattacharyya S, Crippa JA, Martin-Santos R, Winton-Brown T, Fusar- Poli P. Imaging the neural effects of cannabinoids: current status and future opportunities for psychopharmacology. Curr Pharm Des. 2009;15(22):2603-14.
-
(2009)
Curr Pharm Des
, vol.15
, Issue.22
, pp. 2603-2614
-
-
Bhattacharyya, S.1
Crippa, J.A.2
Martin-Santos, R.3
Winton-Brown, T.4
Fusar-Poli, P.5
|